Global Peptide CDMO Market Growth (Status and Outlook) 2025-2031
The report requires updating with new data and is sent in 48 hours after order is placed.
The global FIB-SEM System market size is predicted to grow from US$ 644 million in 2025 to US$ 910 million in 2031; it is expected to grow at a CAGR of 5.9% from 2025 to 2031.
The FIB-SEM system is an electron microscope system that integrates focused electron beams and scanning ion beams. Focused ion beams can be used for micro processing of samples, scanning electron beams can be used for micro imaging and 'two-dimensional' characterization analysis of sample surface morphology, and real-time observation of the FIB processing process. Therefore, the FIB-SEM system can achieve fixed-point etching, deposition, cross-sectional cutting, TEM electron microscopy sample preparation, and micro/nano device preparation of samples Circuit repair, 3D structural characterization, etc.
Global key players of FIB-SEM System include Thermo Fisher Scientific Hitachi and Zeiss, etc. The top three players hold a share over 85%. Japan is the largest market. In terms of product type, Ga Ion Source is the largest segment, occupied for a share of 95%, and in terms of application, Material Science has a share about 40 percent.
Analysis of FIB-SEM system market drivers
1. Demand for semiconductor technology iteration
Advanced process node promotion:
3nm/2nm chip process requires atomic-level defect detection, and FIB-SEM supports nanoscale circuit editing and material composition analysis (such as EDS/EBSD integration) to help improve yield.
3D packaging technology (such as Chiplet) relies on FIB-SEM for through-silicon via (TSV) cross-sectional analysis and interface defect positioning.
Semiconductor material innovation:
The microstructure research of third-generation semiconductors (GaN, SiC) and two-dimensional materials (graphene) requires FIB-SEM to achieve atomic-level resolution imaging (<0.5nm).
2. Biomedical and life science research
Tissue engineering and drug delivery:
FIB-SEM supports cell-material interface imaging, analyzes the distribution of nanoparticles in the body, and accelerates targeted drug development.
Brain neuroscience: 3D reconstruction of the whole brain neural network is achieved through volume electron microscopy (SBEM), promoting the study of the mechanism of neurodegenerative diseases.
Implantable medical devices:
Analysis of nanoscale surface morphology of biocompatible materials (such as degradable stents) to optimize device design.
3. Breakthroughs in materials science
Research and development of new energy materials:
Study on the growth mechanism of lithium dendrites in solid-state batteries requires FIB-SEM combined with low-temperature in-situ electron microscopy technology.
Analysis of hydrogen embrittlement: Observation of metal microscopic crack propagation in transmission electron microscope samples prepared by FIB.
Design of nanocomposite materials:
FIB-SEM supports 3D structural characterization of multimodal materials (such as graphene/metal composites) to help optimize performance.
4. Industry 4.0 and smart manufacturing
Micro-nano manufacturing upgrade:
The complex structure processing of MEMS sensors (such as inertial measurement units) relies on the ion beam direct writing technology of FIB-SEM.
Nanoscale circuit repair of flexible electronics (such as foldable screens) drives the growth of equipment demand.
Intelligent quality control:
AI integrated FIB-SEM system realizes automated defect detection (such as wafer surface particle analysis) to improve production line efficiency.
5. Academic and policy support
Research funding:
Global nanotechnology R&D investment increased by 8% annually (NSF data), and universities/national laboratories purchased FIB-SEM for cutting-edge exploration.
China's '14th Five-Year Plan' focuses on supporting the localization of electron microscopes, giving rise to local equipment demand.
Open source science trends:
FIB-SEM data sharing platforms (such as EMPIAR) promote interdisciplinary cooperation and accelerate technology popularization.
6. Technology integration and innovation
Multimodal combined technology:
FIB-SEM is integrated with Raman spectroscopy/AFM to achieve morphology-composition-mechanics multi-attribute correlation analysis.
In-situ electrical testing: Directly measure carrier transport characteristics on FIB-prepared nanostructures.
AI-assisted analysis:
Deep learning algorithms increase FIB-SEM imaging speed by 3-5 times and reduce the operating threshold.
Market growth forecast and competition focus.
Decisive factors:
Resolution and processing accuracy: Breakthrough to sub-nanometer level (<0.3nm) to support quantum material research.
Automation and data ecology: Develop AI-driven full-process solutions (such as sample preparation-imaging-analysis integration).
Summary: The three core driving forces of semiconductor technology generational evolution, biomedical interdisciplinary integration, and material science paradigm innovation, coupled with policy support and AI technology empowerment, promote FIB-SEM from a scientific research tool to an industrial standard. Chinese companies need to break through the bottlenecks of ion source stability and software algorithms to seize the high-end market.
LP Information, Inc. (LPI) ' newest research report, the “FIB-SEM System Industry Forecast” looks at past sales and reviews total world FIB-SEM System sales in 2024, providing a comprehensive analysis by region and market sector of projected FIB-SEM System sales for 2025 through 2031. With FIB-SEM System sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world FIB-SEM System industry.
This Insight Report provides a comprehensive analysis of the global FIB-SEM System landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on FIB-SEM System portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global FIB-SEM System market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for FIB-SEM System and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global FIB-SEM System.
This report presents a comprehensive overview, market shares, and growth opportunities of FIB-SEM System market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global FIB-SEM System market?
What factors are driving FIB-SEM System market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do FIB-SEM System market opportunities vary by end market size?
How does FIB-SEM System break out by Type, by Application?
The global FIB-SEM System market size is predicted to grow from US$ 644 million in 2025 to US$ 910 million in 2031; it is expected to grow at a CAGR of 5.9% from 2025 to 2031.
The FIB-SEM system is an electron microscope system that integrates focused electron beams and scanning ion beams. Focused ion beams can be used for micro processing of samples, scanning electron beams can be used for micro imaging and 'two-dimensional' characterization analysis of sample surface morphology, and real-time observation of the FIB processing process. Therefore, the FIB-SEM system can achieve fixed-point etching, deposition, cross-sectional cutting, TEM electron microscopy sample preparation, and micro/nano device preparation of samples Circuit repair, 3D structural characterization, etc.
Global key players of FIB-SEM System include Thermo Fisher Scientific Hitachi and Zeiss, etc. The top three players hold a share over 85%. Japan is the largest market. In terms of product type, Ga Ion Source is the largest segment, occupied for a share of 95%, and in terms of application, Material Science has a share about 40 percent.
Analysis of FIB-SEM system market drivers
1. Demand for semiconductor technology iteration
Advanced process node promotion:
3nm/2nm chip process requires atomic-level defect detection, and FIB-SEM supports nanoscale circuit editing and material composition analysis (such as EDS/EBSD integration) to help improve yield.
3D packaging technology (such as Chiplet) relies on FIB-SEM for through-silicon via (TSV) cross-sectional analysis and interface defect positioning.
Semiconductor material innovation:
The microstructure research of third-generation semiconductors (GaN, SiC) and two-dimensional materials (graphene) requires FIB-SEM to achieve atomic-level resolution imaging (<0.5nm).
2. Biomedical and life science research
Tissue engineering and drug delivery:
FIB-SEM supports cell-material interface imaging, analyzes the distribution of nanoparticles in the body, and accelerates targeted drug development.
Brain neuroscience: 3D reconstruction of the whole brain neural network is achieved through volume electron microscopy (SBEM), promoting the study of the mechanism of neurodegenerative diseases.
Implantable medical devices:
Analysis of nanoscale surface morphology of biocompatible materials (such as degradable stents) to optimize device design.
3. Breakthroughs in materials science
Research and development of new energy materials:
Study on the growth mechanism of lithium dendrites in solid-state batteries requires FIB-SEM combined with low-temperature in-situ electron microscopy technology.
Analysis of hydrogen embrittlement: Observation of metal microscopic crack propagation in transmission electron microscope samples prepared by FIB.
Design of nanocomposite materials:
FIB-SEM supports 3D structural characterization of multimodal materials (such as graphene/metal composites) to help optimize performance.
4. Industry 4.0 and smart manufacturing
Micro-nano manufacturing upgrade:
The complex structure processing of MEMS sensors (such as inertial measurement units) relies on the ion beam direct writing technology of FIB-SEM.
Nanoscale circuit repair of flexible electronics (such as foldable screens) drives the growth of equipment demand.
Intelligent quality control:
AI integrated FIB-SEM system realizes automated defect detection (such as wafer surface particle analysis) to improve production line efficiency.
5. Academic and policy support
Research funding:
Global nanotechnology R&D investment increased by 8% annually (NSF data), and universities/national laboratories purchased FIB-SEM for cutting-edge exploration.
China's '14th Five-Year Plan' focuses on supporting the localization of electron microscopes, giving rise to local equipment demand.
Open source science trends:
FIB-SEM data sharing platforms (such as EMPIAR) promote interdisciplinary cooperation and accelerate technology popularization.
6. Technology integration and innovation
Multimodal combined technology:
FIB-SEM is integrated with Raman spectroscopy/AFM to achieve morphology-composition-mechanics multi-attribute correlation analysis.
In-situ electrical testing: Directly measure carrier transport characteristics on FIB-prepared nanostructures.
AI-assisted analysis:
Deep learning algorithms increase FIB-SEM imaging speed by 3-5 times and reduce the operating threshold.
Market growth forecast and competition focus.
Decisive factors:
Resolution and processing accuracy: Breakthrough to sub-nanometer level (<0.3nm) to support quantum material research.
Automation and data ecology: Develop AI-driven full-process solutions (such as sample preparation-imaging-analysis integration).
Summary: The three core driving forces of semiconductor technology generational evolution, biomedical interdisciplinary integration, and material science paradigm innovation, coupled with policy support and AI technology empowerment, promote FIB-SEM from a scientific research tool to an industrial standard. Chinese companies need to break through the bottlenecks of ion source stability and software algorithms to seize the high-end market.
LP Information, Inc. (LPI) ' newest research report, the “FIB-SEM System Industry Forecast” looks at past sales and reviews total world FIB-SEM System sales in 2024, providing a comprehensive analysis by region and market sector of projected FIB-SEM System sales for 2025 through 2031. With FIB-SEM System sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world FIB-SEM System industry.
This Insight Report provides a comprehensive analysis of the global FIB-SEM System landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on FIB-SEM System portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global FIB-SEM System market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for FIB-SEM System and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global FIB-SEM System.
This report presents a comprehensive overview, market shares, and growth opportunities of FIB-SEM System market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Ga Ion Source
- Non-Ga Ion Source
- Material Science
- Life Sciences
- Semiconductor
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Thermo Fisher Scientific
- Hitachi
- Zeiss
- JEOL Ltd
- Tescan Group
- Raith
What is the 10-year outlook for the global FIB-SEM System market?
What factors are driving FIB-SEM System market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do FIB-SEM System market opportunities vary by end market size?
How does FIB-SEM System break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Peptide CDMO Market Size (2020-2031)
2.1.2 Peptide CDMO Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Peptide CDMO by Country/Region (2020, 2024 & 2031)
2.2 Peptide CDMO Segment by Type
2.2.1 APIs and Intermediates
2.2.2 FDF
2.3 Peptide CDMO Market Size by Type
2.3.1 Peptide CDMO Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Peptide CDMO Market Size Market Share by Type (2020-2025)
2.4 Peptide CDMO Segment by Application
2.4.1 Commercial
2.4.2 Academic Research
2.4.3 Other
2.5 Peptide CDMO Market Size by Application
2.5.1 Peptide CDMO Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Peptide CDMO Market Size Market Share by Application (2020-2025)
3 PEPTIDE CDMO MARKET SIZE BY PLAYER
3.1 Peptide CDMO Market Size Market Share by Player
3.1.1 Global Peptide CDMO Revenue by Player (2020-2025)
3.1.2 Global Peptide CDMO Revenue Market Share by Player (2020-2025)
3.2 Global Peptide CDMO Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 PEPTIDE CDMO BY REGION
4.1 Peptide CDMO Market Size by Region (2020-2025)
4.2 Global Peptide CDMO Annual Revenue by Country/Region (2020-2025)
4.3 Americas Peptide CDMO Market Size Growth (2020-2025)
4.4 APAC Peptide CDMO Market Size Growth (2020-2025)
4.5 Europe Peptide CDMO Market Size Growth (2020-2025)
4.6 Middle East & Africa Peptide CDMO Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas Peptide CDMO Market Size by Country (2020-2025)
5.2 Americas Peptide CDMO Market Size by Type (2020-2025)
5.3 Americas Peptide CDMO Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Peptide CDMO Market Size by Region (2020-2025)
6.2 APAC Peptide CDMO Market Size by Type (2020-2025)
6.3 APAC Peptide CDMO Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Peptide CDMO Market Size by Country (2020-2025)
7.2 Europe Peptide CDMO Market Size by Type (2020-2025)
7.3 Europe Peptide CDMO Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Peptide CDMO by Region (2020-2025)
8.2 Middle East & Africa Peptide CDMO Market Size by Type (2020-2025)
8.3 Middle East & Africa Peptide CDMO Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL PEPTIDE CDMO MARKET FORECAST
10.1 Global Peptide CDMO Forecast by Region (2026-2031)
10.1.1 Global Peptide CDMO Forecast by Region (2026-2031)
10.1.2 Americas Peptide CDMO Forecast
10.1.3 APAC Peptide CDMO Forecast
10.1.4 Europe Peptide CDMO Forecast
10.1.5 Middle East & Africa Peptide CDMO Forecast
10.2 Americas Peptide CDMO Forecast by Country (2026-2031)
10.2.1 United States Market Peptide CDMO Forecast
10.2.2 Canada Market Peptide CDMO Forecast
10.2.3 Mexico Market Peptide CDMO Forecast
10.2.4 Brazil Market Peptide CDMO Forecast
10.3 APAC Peptide CDMO Forecast by Region (2026-2031)
10.3.1 China Peptide CDMO Market Forecast
10.3.2 Japan Market Peptide CDMO Forecast
10.3.3 Korea Market Peptide CDMO Forecast
10.3.4 Southeast Asia Market Peptide CDMO Forecast
10.3.5 India Market Peptide CDMO Forecast
10.3.6 Australia Market Peptide CDMO Forecast
10.4 Europe Peptide CDMO Forecast by Country (2026-2031)
10.4.1 Germany Market Peptide CDMO Forecast
10.4.2 France Market Peptide CDMO Forecast
10.4.3 UK Market Peptide CDMO Forecast
10.4.4 Italy Market Peptide CDMO Forecast
10.4.5 Russia Market Peptide CDMO Forecast
10.5 Middle East & Africa Peptide CDMO Forecast by Region (2026-2031)
10.5.1 Egypt Market Peptide CDMO Forecast
10.5.2 South Africa Market Peptide CDMO Forecast
10.5.3 Israel Market Peptide CDMO Forecast
10.5.4 Turkey Market Peptide CDMO Forecast
10.6 Global Peptide CDMO Forecast by Type (2026-2031)
10.7 Global Peptide CDMO Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Peptide CDMO Forecast
11 KEY PLAYERS ANALYSIS
11.1 Bachem
11.1.1 Bachem Company Information
11.1.2 Bachem Peptide CDMO Product Offered
11.1.3 Bachem Peptide CDMO Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Bachem Main Business Overview
11.1.5 Bachem Latest Developments
11.2 PolyPeptide
11.2.1 PolyPeptide Company Information
11.2.2 PolyPeptide Peptide CDMO Product Offered
11.2.3 PolyPeptide Peptide CDMO Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 PolyPeptide Main Business Overview
11.2.5 PolyPeptide Latest Developments
11.3 CordenPharma
11.3.1 CordenPharma Company Information
11.3.2 CordenPharma Peptide CDMO Product Offered
11.3.3 CordenPharma Peptide CDMO Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 CordenPharma Main Business Overview
11.3.5 CordenPharma Latest Developments
11.4 AmbioPharm
11.4.1 AmbioPharm Company Information
11.4.2 AmbioPharm Peptide CDMO Product Offered
11.4.3 AmbioPharm Peptide CDMO Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 AmbioPharm Main Business Overview
11.4.5 AmbioPharm Latest Developments
11.5 USV Peptides
11.5.1 USV Peptides Company Information
11.5.2 USV Peptides Peptide CDMO Product Offered
11.5.3 USV Peptides Peptide CDMO Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 USV Peptides Main Business Overview
11.5.5 USV Peptides Latest Developments
11.6 Thermofischer
11.6.1 Thermofischer Company Information
11.6.2 Thermofischer Peptide CDMO Product Offered
11.6.3 Thermofischer Peptide CDMO Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Thermofischer Main Business Overview
11.6.5 Thermofischer Latest Developments
11.7 Bio Basic
11.7.1 Bio Basic Company Information
11.7.2 Bio Basic Peptide CDMO Product Offered
11.7.3 Bio Basic Peptide CDMO Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Bio Basic Main Business Overview
11.7.5 Bio Basic Latest Developments
11.8 JPT
11.8.1 JPT Company Information
11.8.2 JPT Peptide CDMO Product Offered
11.8.3 JPT Peptide CDMO Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 JPT Main Business Overview
11.8.5 JPT Latest Developments
11.9 Genscript
11.9.1 Genscript Company Information
11.9.2 Genscript Peptide CDMO Product Offered
11.9.3 Genscript Peptide CDMO Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Genscript Main Business Overview
11.9.5 Genscript Latest Developments
11.10 Xinbang Pharma
11.10.1 Xinbang Pharma Company Information
11.10.2 Xinbang Pharma Peptide CDMO Product Offered
11.10.3 Xinbang Pharma Peptide CDMO Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Xinbang Pharma Main Business Overview
11.10.5 Xinbang Pharma Latest Developments
11.11 ScinoPharm
11.11.1 ScinoPharm Company Information
11.11.2 ScinoPharm Peptide CDMO Product Offered
11.11.3 ScinoPharm Peptide CDMO Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 ScinoPharm Main Business Overview
11.11.5 ScinoPharm Latest Developments
11.12 SN Biopharm
11.12.1 SN Biopharm Company Information
11.12.2 SN Biopharm Peptide CDMO Product Offered
11.12.3 SN Biopharm Peptide CDMO Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 SN Biopharm Main Business Overview
11.12.5 SN Biopharm Latest Developments
11.13 CBL
11.13.1 CBL Company Information
11.13.2 CBL Peptide CDMO Product Offered
11.13.3 CBL Peptide CDMO Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 CBL Main Business Overview
11.13.5 CBL Latest Developments
11.14 Piramal Pharma
11.14.1 Piramal Pharma Company Information
11.14.2 Piramal Pharma Peptide CDMO Product Offered
11.14.3 Piramal Pharma Peptide CDMO Revenue, Gross Margin and Market Share (2020-2025)
11.14.4 Piramal Pharma Main Business Overview
11.14.5 Piramal Pharma Latest Developments
11.15 CPC Scientific
11.15.1 CPC Scientific Company Information
11.15.2 CPC Scientific Peptide CDMO Product Offered
11.15.3 CPC Scientific Peptide CDMO Revenue, Gross Margin and Market Share (2020-2025)
11.15.4 CPC Scientific Main Business Overview
11.15.5 CPC Scientific Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Peptide CDMO Market Size (2020-2031)
2.1.2 Peptide CDMO Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Peptide CDMO by Country/Region (2020, 2024 & 2031)
2.2 Peptide CDMO Segment by Type
2.2.1 APIs and Intermediates
2.2.2 FDF
2.3 Peptide CDMO Market Size by Type
2.3.1 Peptide CDMO Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Peptide CDMO Market Size Market Share by Type (2020-2025)
2.4 Peptide CDMO Segment by Application
2.4.1 Commercial
2.4.2 Academic Research
2.4.3 Other
2.5 Peptide CDMO Market Size by Application
2.5.1 Peptide CDMO Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Peptide CDMO Market Size Market Share by Application (2020-2025)
3 PEPTIDE CDMO MARKET SIZE BY PLAYER
3.1 Peptide CDMO Market Size Market Share by Player
3.1.1 Global Peptide CDMO Revenue by Player (2020-2025)
3.1.2 Global Peptide CDMO Revenue Market Share by Player (2020-2025)
3.2 Global Peptide CDMO Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 PEPTIDE CDMO BY REGION
4.1 Peptide CDMO Market Size by Region (2020-2025)
4.2 Global Peptide CDMO Annual Revenue by Country/Region (2020-2025)
4.3 Americas Peptide CDMO Market Size Growth (2020-2025)
4.4 APAC Peptide CDMO Market Size Growth (2020-2025)
4.5 Europe Peptide CDMO Market Size Growth (2020-2025)
4.6 Middle East & Africa Peptide CDMO Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas Peptide CDMO Market Size by Country (2020-2025)
5.2 Americas Peptide CDMO Market Size by Type (2020-2025)
5.3 Americas Peptide CDMO Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Peptide CDMO Market Size by Region (2020-2025)
6.2 APAC Peptide CDMO Market Size by Type (2020-2025)
6.3 APAC Peptide CDMO Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Peptide CDMO Market Size by Country (2020-2025)
7.2 Europe Peptide CDMO Market Size by Type (2020-2025)
7.3 Europe Peptide CDMO Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Peptide CDMO by Region (2020-2025)
8.2 Middle East & Africa Peptide CDMO Market Size by Type (2020-2025)
8.3 Middle East & Africa Peptide CDMO Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL PEPTIDE CDMO MARKET FORECAST
10.1 Global Peptide CDMO Forecast by Region (2026-2031)
10.1.1 Global Peptide CDMO Forecast by Region (2026-2031)
10.1.2 Americas Peptide CDMO Forecast
10.1.3 APAC Peptide CDMO Forecast
10.1.4 Europe Peptide CDMO Forecast
10.1.5 Middle East & Africa Peptide CDMO Forecast
10.2 Americas Peptide CDMO Forecast by Country (2026-2031)
10.2.1 United States Market Peptide CDMO Forecast
10.2.2 Canada Market Peptide CDMO Forecast
10.2.3 Mexico Market Peptide CDMO Forecast
10.2.4 Brazil Market Peptide CDMO Forecast
10.3 APAC Peptide CDMO Forecast by Region (2026-2031)
10.3.1 China Peptide CDMO Market Forecast
10.3.2 Japan Market Peptide CDMO Forecast
10.3.3 Korea Market Peptide CDMO Forecast
10.3.4 Southeast Asia Market Peptide CDMO Forecast
10.3.5 India Market Peptide CDMO Forecast
10.3.6 Australia Market Peptide CDMO Forecast
10.4 Europe Peptide CDMO Forecast by Country (2026-2031)
10.4.1 Germany Market Peptide CDMO Forecast
10.4.2 France Market Peptide CDMO Forecast
10.4.3 UK Market Peptide CDMO Forecast
10.4.4 Italy Market Peptide CDMO Forecast
10.4.5 Russia Market Peptide CDMO Forecast
10.5 Middle East & Africa Peptide CDMO Forecast by Region (2026-2031)
10.5.1 Egypt Market Peptide CDMO Forecast
10.5.2 South Africa Market Peptide CDMO Forecast
10.5.3 Israel Market Peptide CDMO Forecast
10.5.4 Turkey Market Peptide CDMO Forecast
10.6 Global Peptide CDMO Forecast by Type (2026-2031)
10.7 Global Peptide CDMO Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Peptide CDMO Forecast
11 KEY PLAYERS ANALYSIS
11.1 Bachem
11.1.1 Bachem Company Information
11.1.2 Bachem Peptide CDMO Product Offered
11.1.3 Bachem Peptide CDMO Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Bachem Main Business Overview
11.1.5 Bachem Latest Developments
11.2 PolyPeptide
11.2.1 PolyPeptide Company Information
11.2.2 PolyPeptide Peptide CDMO Product Offered
11.2.3 PolyPeptide Peptide CDMO Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 PolyPeptide Main Business Overview
11.2.5 PolyPeptide Latest Developments
11.3 CordenPharma
11.3.1 CordenPharma Company Information
11.3.2 CordenPharma Peptide CDMO Product Offered
11.3.3 CordenPharma Peptide CDMO Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 CordenPharma Main Business Overview
11.3.5 CordenPharma Latest Developments
11.4 AmbioPharm
11.4.1 AmbioPharm Company Information
11.4.2 AmbioPharm Peptide CDMO Product Offered
11.4.3 AmbioPharm Peptide CDMO Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 AmbioPharm Main Business Overview
11.4.5 AmbioPharm Latest Developments
11.5 USV Peptides
11.5.1 USV Peptides Company Information
11.5.2 USV Peptides Peptide CDMO Product Offered
11.5.3 USV Peptides Peptide CDMO Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 USV Peptides Main Business Overview
11.5.5 USV Peptides Latest Developments
11.6 Thermofischer
11.6.1 Thermofischer Company Information
11.6.2 Thermofischer Peptide CDMO Product Offered
11.6.3 Thermofischer Peptide CDMO Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Thermofischer Main Business Overview
11.6.5 Thermofischer Latest Developments
11.7 Bio Basic
11.7.1 Bio Basic Company Information
11.7.2 Bio Basic Peptide CDMO Product Offered
11.7.3 Bio Basic Peptide CDMO Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Bio Basic Main Business Overview
11.7.5 Bio Basic Latest Developments
11.8 JPT
11.8.1 JPT Company Information
11.8.2 JPT Peptide CDMO Product Offered
11.8.3 JPT Peptide CDMO Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 JPT Main Business Overview
11.8.5 JPT Latest Developments
11.9 Genscript
11.9.1 Genscript Company Information
11.9.2 Genscript Peptide CDMO Product Offered
11.9.3 Genscript Peptide CDMO Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Genscript Main Business Overview
11.9.5 Genscript Latest Developments
11.10 Xinbang Pharma
11.10.1 Xinbang Pharma Company Information
11.10.2 Xinbang Pharma Peptide CDMO Product Offered
11.10.3 Xinbang Pharma Peptide CDMO Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Xinbang Pharma Main Business Overview
11.10.5 Xinbang Pharma Latest Developments
11.11 ScinoPharm
11.11.1 ScinoPharm Company Information
11.11.2 ScinoPharm Peptide CDMO Product Offered
11.11.3 ScinoPharm Peptide CDMO Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 ScinoPharm Main Business Overview
11.11.5 ScinoPharm Latest Developments
11.12 SN Biopharm
11.12.1 SN Biopharm Company Information
11.12.2 SN Biopharm Peptide CDMO Product Offered
11.12.3 SN Biopharm Peptide CDMO Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 SN Biopharm Main Business Overview
11.12.5 SN Biopharm Latest Developments
11.13 CBL
11.13.1 CBL Company Information
11.13.2 CBL Peptide CDMO Product Offered
11.13.3 CBL Peptide CDMO Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 CBL Main Business Overview
11.13.5 CBL Latest Developments
11.14 Piramal Pharma
11.14.1 Piramal Pharma Company Information
11.14.2 Piramal Pharma Peptide CDMO Product Offered
11.14.3 Piramal Pharma Peptide CDMO Revenue, Gross Margin and Market Share (2020-2025)
11.14.4 Piramal Pharma Main Business Overview
11.14.5 Piramal Pharma Latest Developments
11.15 CPC Scientific
11.15.1 CPC Scientific Company Information
11.15.2 CPC Scientific Peptide CDMO Product Offered
11.15.3 CPC Scientific Peptide CDMO Revenue, Gross Margin and Market Share (2020-2025)
11.15.4 CPC Scientific Main Business Overview
11.15.5 CPC Scientific Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Peptide CDMO Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Peptide CDMO Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of APIs and Intermediates
Table 4. Major Players of FDF
Table 5. Peptide CDMO Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 6. Global Peptide CDMO Market Size by Type (2020-2025) & ($ millions)
Table 7. Global Peptide CDMO Market Size Market Share by Type (2020-2025)
Table 8. Peptide CDMO Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global Peptide CDMO Market Size by Application (2020-2025) & ($ millions)
Table 10. Global Peptide CDMO Market Size Market Share by Application (2020-2025)
Table 11. Global Peptide CDMO Revenue by Player (2020-2025) & ($ millions)
Table 12. Global Peptide CDMO Revenue Market Share by Player (2020-2025)
Table 13. Peptide CDMO Key Players Head office and Products Offered
Table 14. Peptide CDMO Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Peptide CDMO Market Size by Region (2020-2025) & ($ millions)
Table 18. Global Peptide CDMO Market Size Market Share by Region (2020-2025)
Table 19. Global Peptide CDMO Revenue by Country/Region (2020-2025) & ($ millions)
Table 20. Global Peptide CDMO Revenue Market Share by Country/Region (2020-2025)
Table 21. Americas Peptide CDMO Market Size by Country (2020-2025) & ($ millions)
Table 22. Americas Peptide CDMO Market Size Market Share by Country (2020-2025)
Table 23. Americas Peptide CDMO Market Size by Type (2020-2025) & ($ millions)
Table 24. Americas Peptide CDMO Market Size Market Share by Type (2020-2025)
Table 25. Americas Peptide CDMO Market Size by Application (2020-2025) & ($ millions)
Table 26. Americas Peptide CDMO Market Size Market Share by Application (2020-2025)
Table 27. APAC Peptide CDMO Market Size by Region (2020-2025) & ($ millions)
Table 28. APAC Peptide CDMO Market Size Market Share by Region (2020-2025)
Table 29. APAC Peptide CDMO Market Size by Type (2020-2025) & ($ millions)
Table 30. APAC Peptide CDMO Market Size by Application (2020-2025) & ($ millions)
Table 31. Europe Peptide CDMO Market Size by Country (2020-2025) & ($ millions)
Table 32. Europe Peptide CDMO Market Size Market Share by Country (2020-2025)
Table 33. Europe Peptide CDMO Market Size by Type (2020-2025) & ($ millions)
Table 34. Europe Peptide CDMO Market Size by Application (2020-2025) & ($ millions)
Table 35. Middle East & Africa Peptide CDMO Market Size by Region (2020-2025) & ($ millions)
Table 36. Middle East & Africa Peptide CDMO Market Size by Type (2020-2025) & ($ millions)
Table 37. Middle East & Africa Peptide CDMO Market Size by Application (2020-2025) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Peptide CDMO
Table 39. Key Market Challenges & Risks of Peptide CDMO
Table 40. Key Industry Trends of Peptide CDMO
Table 41. Global Peptide CDMO Market Size Forecast by Region (2026-2031) & ($ millions)
Table 42. Global Peptide CDMO Market Size Market Share Forecast by Region (2026-2031)
Table 43. Global Peptide CDMO Market Size Forecast by Type (2026-2031) & ($ millions)
Table 44. Global Peptide CDMO Market Size Forecast by Application (2026-2031) & ($ millions)
Table 45. Bachem Details, Company Type, Peptide CDMO Area Served and Its Competitors
Table 46. Bachem Peptide CDMO Product Offered
Table 47. Bachem Peptide CDMO Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 48. Bachem Main Business
Table 49. Bachem Latest Developments
Table 50. PolyPeptide Details, Company Type, Peptide CDMO Area Served and Its Competitors
Table 51. PolyPeptide Peptide CDMO Product Offered
Table 52. PolyPeptide Peptide CDMO Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 53. PolyPeptide Main Business
Table 54. PolyPeptide Latest Developments
Table 55. CordenPharma Details, Company Type, Peptide CDMO Area Served and Its Competitors
Table 56. CordenPharma Peptide CDMO Product Offered
Table 57. CordenPharma Peptide CDMO Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 58. CordenPharma Main Business
Table 59. CordenPharma Latest Developments
Table 60. AmbioPharm Details, Company Type, Peptide CDMO Area Served and Its Competitors
Table 61. AmbioPharm Peptide CDMO Product Offered
Table 62. AmbioPharm Peptide CDMO Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 63. AmbioPharm Main Business
Table 64. AmbioPharm Latest Developments
Table 65. USV Peptides Details, Company Type, Peptide CDMO Area Served and Its Competitors
Table 66. USV Peptides Peptide CDMO Product Offered
Table 67. USV Peptides Peptide CDMO Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 68. USV Peptides Main Business
Table 69. USV Peptides Latest Developments
Table 70. Thermofischer Details, Company Type, Peptide CDMO Area Served and Its Competitors
Table 71. Thermofischer Peptide CDMO Product Offered
Table 72. Thermofischer Peptide CDMO Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 73. Thermofischer Main Business
Table 74. Thermofischer Latest Developments
Table 75. Bio Basic Details, Company Type, Peptide CDMO Area Served and Its Competitors
Table 76. Bio Basic Peptide CDMO Product Offered
Table 77. Bio Basic Peptide CDMO Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 78. Bio Basic Main Business
Table 79. Bio Basic Latest Developments
Table 80. JPT Details, Company Type, Peptide CDMO Area Served and Its Competitors
Table 81. JPT Peptide CDMO Product Offered
Table 82. JPT Peptide CDMO Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 83. JPT Main Business
Table 84. JPT Latest Developments
Table 85. Genscript Details, Company Type, Peptide CDMO Area Served and Its Competitors
Table 86. Genscript Peptide CDMO Product Offered
Table 87. Genscript Peptide CDMO Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 88. Genscript Main Business
Table 89. Genscript Latest Developments
Table 90. Xinbang Pharma Details, Company Type, Peptide CDMO Area Served and Its Competitors
Table 91. Xinbang Pharma Peptide CDMO Product Offered
Table 92. Xinbang Pharma Peptide CDMO Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 93. Xinbang Pharma Main Business
Table 94. Xinbang Pharma Latest Developments
Table 95. ScinoPharm Details, Company Type, Peptide CDMO Area Served and Its Competitors
Table 96. ScinoPharm Peptide CDMO Product Offered
Table 97. ScinoPharm Peptide CDMO Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 98. ScinoPharm Main Business
Table 99. ScinoPharm Latest Developments
Table 100. SN Biopharm Details, Company Type, Peptide CDMO Area Served and Its Competitors
Table 101. SN Biopharm Peptide CDMO Product Offered
Table 102. SN Biopharm Peptide CDMO Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 103. SN Biopharm Main Business
Table 104. SN Biopharm Latest Developments
Table 105. CBL Details, Company Type, Peptide CDMO Area Served and Its Competitors
Table 106. CBL Peptide CDMO Product Offered
Table 107. CBL Peptide CDMO Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 108. CBL Main Business
Table 109. CBL Latest Developments
Table 110. Piramal Pharma Details, Company Type, Peptide CDMO Area Served and Its Competitors
Table 111. Piramal Pharma Peptide CDMO Product Offered
Table 112. Piramal Pharma Peptide CDMO Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 113. Piramal Pharma Main Business
Table 114. Piramal Pharma Latest Developments
Table 115. CPC Scientific Details, Company Type, Peptide CDMO Area Served and Its Competitors
Table 116. CPC Scientific Peptide CDMO Product Offered
Table 117. CPC Scientific Peptide CDMO Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 118. CPC Scientific Main Business
Table 119. CPC Scientific Latest Developments
Table 1. Peptide CDMO Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Peptide CDMO Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of APIs and Intermediates
Table 4. Major Players of FDF
Table 5. Peptide CDMO Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 6. Global Peptide CDMO Market Size by Type (2020-2025) & ($ millions)
Table 7. Global Peptide CDMO Market Size Market Share by Type (2020-2025)
Table 8. Peptide CDMO Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global Peptide CDMO Market Size by Application (2020-2025) & ($ millions)
Table 10. Global Peptide CDMO Market Size Market Share by Application (2020-2025)
Table 11. Global Peptide CDMO Revenue by Player (2020-2025) & ($ millions)
Table 12. Global Peptide CDMO Revenue Market Share by Player (2020-2025)
Table 13. Peptide CDMO Key Players Head office and Products Offered
Table 14. Peptide CDMO Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Peptide CDMO Market Size by Region (2020-2025) & ($ millions)
Table 18. Global Peptide CDMO Market Size Market Share by Region (2020-2025)
Table 19. Global Peptide CDMO Revenue by Country/Region (2020-2025) & ($ millions)
Table 20. Global Peptide CDMO Revenue Market Share by Country/Region (2020-2025)
Table 21. Americas Peptide CDMO Market Size by Country (2020-2025) & ($ millions)
Table 22. Americas Peptide CDMO Market Size Market Share by Country (2020-2025)
Table 23. Americas Peptide CDMO Market Size by Type (2020-2025) & ($ millions)
Table 24. Americas Peptide CDMO Market Size Market Share by Type (2020-2025)
Table 25. Americas Peptide CDMO Market Size by Application (2020-2025) & ($ millions)
Table 26. Americas Peptide CDMO Market Size Market Share by Application (2020-2025)
Table 27. APAC Peptide CDMO Market Size by Region (2020-2025) & ($ millions)
Table 28. APAC Peptide CDMO Market Size Market Share by Region (2020-2025)
Table 29. APAC Peptide CDMO Market Size by Type (2020-2025) & ($ millions)
Table 30. APAC Peptide CDMO Market Size by Application (2020-2025) & ($ millions)
Table 31. Europe Peptide CDMO Market Size by Country (2020-2025) & ($ millions)
Table 32. Europe Peptide CDMO Market Size Market Share by Country (2020-2025)
Table 33. Europe Peptide CDMO Market Size by Type (2020-2025) & ($ millions)
Table 34. Europe Peptide CDMO Market Size by Application (2020-2025) & ($ millions)
Table 35. Middle East & Africa Peptide CDMO Market Size by Region (2020-2025) & ($ millions)
Table 36. Middle East & Africa Peptide CDMO Market Size by Type (2020-2025) & ($ millions)
Table 37. Middle East & Africa Peptide CDMO Market Size by Application (2020-2025) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Peptide CDMO
Table 39. Key Market Challenges & Risks of Peptide CDMO
Table 40. Key Industry Trends of Peptide CDMO
Table 41. Global Peptide CDMO Market Size Forecast by Region (2026-2031) & ($ millions)
Table 42. Global Peptide CDMO Market Size Market Share Forecast by Region (2026-2031)
Table 43. Global Peptide CDMO Market Size Forecast by Type (2026-2031) & ($ millions)
Table 44. Global Peptide CDMO Market Size Forecast by Application (2026-2031) & ($ millions)
Table 45. Bachem Details, Company Type, Peptide CDMO Area Served and Its Competitors
Table 46. Bachem Peptide CDMO Product Offered
Table 47. Bachem Peptide CDMO Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 48. Bachem Main Business
Table 49. Bachem Latest Developments
Table 50. PolyPeptide Details, Company Type, Peptide CDMO Area Served and Its Competitors
Table 51. PolyPeptide Peptide CDMO Product Offered
Table 52. PolyPeptide Peptide CDMO Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 53. PolyPeptide Main Business
Table 54. PolyPeptide Latest Developments
Table 55. CordenPharma Details, Company Type, Peptide CDMO Area Served and Its Competitors
Table 56. CordenPharma Peptide CDMO Product Offered
Table 57. CordenPharma Peptide CDMO Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 58. CordenPharma Main Business
Table 59. CordenPharma Latest Developments
Table 60. AmbioPharm Details, Company Type, Peptide CDMO Area Served and Its Competitors
Table 61. AmbioPharm Peptide CDMO Product Offered
Table 62. AmbioPharm Peptide CDMO Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 63. AmbioPharm Main Business
Table 64. AmbioPharm Latest Developments
Table 65. USV Peptides Details, Company Type, Peptide CDMO Area Served and Its Competitors
Table 66. USV Peptides Peptide CDMO Product Offered
Table 67. USV Peptides Peptide CDMO Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 68. USV Peptides Main Business
Table 69. USV Peptides Latest Developments
Table 70. Thermofischer Details, Company Type, Peptide CDMO Area Served and Its Competitors
Table 71. Thermofischer Peptide CDMO Product Offered
Table 72. Thermofischer Peptide CDMO Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 73. Thermofischer Main Business
Table 74. Thermofischer Latest Developments
Table 75. Bio Basic Details, Company Type, Peptide CDMO Area Served and Its Competitors
Table 76. Bio Basic Peptide CDMO Product Offered
Table 77. Bio Basic Peptide CDMO Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 78. Bio Basic Main Business
Table 79. Bio Basic Latest Developments
Table 80. JPT Details, Company Type, Peptide CDMO Area Served and Its Competitors
Table 81. JPT Peptide CDMO Product Offered
Table 82. JPT Peptide CDMO Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 83. JPT Main Business
Table 84. JPT Latest Developments
Table 85. Genscript Details, Company Type, Peptide CDMO Area Served and Its Competitors
Table 86. Genscript Peptide CDMO Product Offered
Table 87. Genscript Peptide CDMO Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 88. Genscript Main Business
Table 89. Genscript Latest Developments
Table 90. Xinbang Pharma Details, Company Type, Peptide CDMO Area Served and Its Competitors
Table 91. Xinbang Pharma Peptide CDMO Product Offered
Table 92. Xinbang Pharma Peptide CDMO Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 93. Xinbang Pharma Main Business
Table 94. Xinbang Pharma Latest Developments
Table 95. ScinoPharm Details, Company Type, Peptide CDMO Area Served and Its Competitors
Table 96. ScinoPharm Peptide CDMO Product Offered
Table 97. ScinoPharm Peptide CDMO Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 98. ScinoPharm Main Business
Table 99. ScinoPharm Latest Developments
Table 100. SN Biopharm Details, Company Type, Peptide CDMO Area Served and Its Competitors
Table 101. SN Biopharm Peptide CDMO Product Offered
Table 102. SN Biopharm Peptide CDMO Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 103. SN Biopharm Main Business
Table 104. SN Biopharm Latest Developments
Table 105. CBL Details, Company Type, Peptide CDMO Area Served and Its Competitors
Table 106. CBL Peptide CDMO Product Offered
Table 107. CBL Peptide CDMO Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 108. CBL Main Business
Table 109. CBL Latest Developments
Table 110. Piramal Pharma Details, Company Type, Peptide CDMO Area Served and Its Competitors
Table 111. Piramal Pharma Peptide CDMO Product Offered
Table 112. Piramal Pharma Peptide CDMO Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 113. Piramal Pharma Main Business
Table 114. Piramal Pharma Latest Developments
Table 115. CPC Scientific Details, Company Type, Peptide CDMO Area Served and Its Competitors
Table 116. CPC Scientific Peptide CDMO Product Offered
Table 117. CPC Scientific Peptide CDMO Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 118. CPC Scientific Main Business
Table 119. CPC Scientific Latest Developments
LIST OF FIGURES
Figure 1. Peptide CDMO Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Peptide CDMO Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Peptide CDMO Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Peptide CDMO Sales Market Share by Country/Region (2024)
Figure 8. Peptide CDMO Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Peptide CDMO Market Size Market Share by Type in 2024
Figure 10. Peptide CDMO in Commercial
Figure 11. Global Peptide CDMO Market: Commercial (2020-2025) & ($ millions)
Figure 12. Peptide CDMO in Academic Research
Figure 13. Global Peptide CDMO Market: Academic Research (2020-2025) & ($ millions)
Figure 14. Peptide CDMO in Other
Figure 15. Global Peptide CDMO Market: Other (2020-2025) & ($ millions)
Figure 16. Global Peptide CDMO Market Size Market Share by Application in 2024
Figure 17. Global Peptide CDMO Revenue Market Share by Player in 2024
Figure 18. Global Peptide CDMO Market Size Market Share by Region (2020-2025)
Figure 19. Americas Peptide CDMO Market Size 2020-2025 ($ millions)
Figure 20. APAC Peptide CDMO Market Size 2020-2025 ($ millions)
Figure 21. Europe Peptide CDMO Market Size 2020-2025 ($ millions)
Figure 22. Middle East & Africa Peptide CDMO Market Size 2020-2025 ($ millions)
Figure 23. Americas Peptide CDMO Value Market Share by Country in 2024
Figure 24. United States Peptide CDMO Market Size Growth 2020-2025 ($ millions)
Figure 25. Canada Peptide CDMO Market Size Growth 2020-2025 ($ millions)
Figure 26. Mexico Peptide CDMO Market Size Growth 2020-2025 ($ millions)
Figure 27. Brazil Peptide CDMO Market Size Growth 2020-2025 ($ millions)
Figure 28. APAC Peptide CDMO Market Size Market Share by Region in 2024
Figure 29. APAC Peptide CDMO Market Size Market Share by Type (2020-2025)
Figure 30. APAC Peptide CDMO Market Size Market Share by Application (2020-2025)
Figure 31. China Peptide CDMO Market Size Growth 2020-2025 ($ millions)
Figure 32. Japan Peptide CDMO Market Size Growth 2020-2025 ($ millions)
Figure 33. South Korea Peptide CDMO Market Size Growth 2020-2025 ($ millions)
Figure 34. Southeast Asia Peptide CDMO Market Size Growth 2020-2025 ($ millions)
Figure 35. India Peptide CDMO Market Size Growth 2020-2025 ($ millions)
Figure 36. Australia Peptide CDMO Market Size Growth 2020-2025 ($ millions)
Figure 37. Europe Peptide CDMO Market Size Market Share by Country in 2024
Figure 38. Europe Peptide CDMO Market Size Market Share by Type (2020-2025)
Figure 39. Europe Peptide CDMO Market Size Market Share by Application (2020-2025)
Figure 40. Germany Peptide CDMO Market Size Growth 2020-2025 ($ millions)
Figure 41. France Peptide CDMO Market Size Growth 2020-2025 ($ millions)
Figure 42. UK Peptide CDMO Market Size Growth 2020-2025 ($ millions)
Figure 43. Italy Peptide CDMO Market Size Growth 2020-2025 ($ millions)
Figure 44. Russia Peptide CDMO Market Size Growth 2020-2025 ($ millions)
Figure 45. Middle East & Africa Peptide CDMO Market Size Market Share by Region (2020-2025)
Figure 46. Middle East & Africa Peptide CDMO Market Size Market Share by Type (2020-2025)
Figure 47. Middle East & Africa Peptide CDMO Market Size Market Share by Application (2020-2025)
Figure 48. Egypt Peptide CDMO Market Size Growth 2020-2025 ($ millions)
Figure 49. South Africa Peptide CDMO Market Size Growth 2020-2025 ($ millions)
Figure 50. Israel Peptide CDMO Market Size Growth 2020-2025 ($ millions)
Figure 51. Turkey Peptide CDMO Market Size Growth 2020-2025 ($ millions)
Figure 52. GCC Countries Peptide CDMO Market Size Growth 2020-2025 ($ millions)
Figure 53. Americas Peptide CDMO Market Size 2026-2031 ($ millions)
Figure 54. APAC Peptide CDMO Market Size 2026-2031 ($ millions)
Figure 55. Europe Peptide CDMO Market Size 2026-2031 ($ millions)
Figure 56. Middle East & Africa Peptide CDMO Market Size 2026-2031 ($ millions)
Figure 57. United States Peptide CDMO Market Size 2026-2031 ($ millions)
Figure 58. Canada Peptide CDMO Market Size 2026-2031 ($ millions)
Figure 59. Mexico Peptide CDMO Market Size 2026-2031 ($ millions)
Figure 60. Brazil Peptide CDMO Market Size 2026-2031 ($ millions)
Figure 61. China Peptide CDMO Market Size 2026-2031 ($ millions)
Figure 62. Japan Peptide CDMO Market Size 2026-2031 ($ millions)
Figure 63. Korea Peptide CDMO Market Size 2026-2031 ($ millions)
Figure 64. Southeast Asia Peptide CDMO Market Size 2026-2031 ($ millions)
Figure 65. India Peptide CDMO Market Size 2026-2031 ($ millions)
Figure 66. Australia Peptide CDMO Market Size 2026-2031 ($ millions)
Figure 67. Germany Peptide CDMO Market Size 2026-2031 ($ millions)
Figure 68. France Peptide CDMO Market Size 2026-2031 ($ millions)
Figure 69. UK Peptide CDMO Market Size 2026-2031 ($ millions)
Figure 70. Italy Peptide CDMO Market Size 2026-2031 ($ millions)
Figure 71. Russia Peptide CDMO Market Size 2026-2031 ($ millions)
Figure 72. Egypt Peptide CDMO Market Size 2026-2031 ($ millions)
Figure 73. South Africa Peptide CDMO Market Size 2026-2031 ($ millions)
Figure 74. Israel Peptide CDMO Market Size 2026-2031 ($ millions)
Figure 75. Turkey Peptide CDMO Market Size 2026-2031 ($ millions)
Figure 76. Global Peptide CDMO Market Size Market Share Forecast by Type (2026-2031)
Figure 77. Global Peptide CDMO Market Size Market Share Forecast by Application (2026-2031)
Figure 78. GCC Countries Peptide CDMO Market Size 2026-2031 ($ millions)
Figure 1. Peptide CDMO Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Peptide CDMO Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Peptide CDMO Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Peptide CDMO Sales Market Share by Country/Region (2024)
Figure 8. Peptide CDMO Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Peptide CDMO Market Size Market Share by Type in 2024
Figure 10. Peptide CDMO in Commercial
Figure 11. Global Peptide CDMO Market: Commercial (2020-2025) & ($ millions)
Figure 12. Peptide CDMO in Academic Research
Figure 13. Global Peptide CDMO Market: Academic Research (2020-2025) & ($ millions)
Figure 14. Peptide CDMO in Other
Figure 15. Global Peptide CDMO Market: Other (2020-2025) & ($ millions)
Figure 16. Global Peptide CDMO Market Size Market Share by Application in 2024
Figure 17. Global Peptide CDMO Revenue Market Share by Player in 2024
Figure 18. Global Peptide CDMO Market Size Market Share by Region (2020-2025)
Figure 19. Americas Peptide CDMO Market Size 2020-2025 ($ millions)
Figure 20. APAC Peptide CDMO Market Size 2020-2025 ($ millions)
Figure 21. Europe Peptide CDMO Market Size 2020-2025 ($ millions)
Figure 22. Middle East & Africa Peptide CDMO Market Size 2020-2025 ($ millions)
Figure 23. Americas Peptide CDMO Value Market Share by Country in 2024
Figure 24. United States Peptide CDMO Market Size Growth 2020-2025 ($ millions)
Figure 25. Canada Peptide CDMO Market Size Growth 2020-2025 ($ millions)
Figure 26. Mexico Peptide CDMO Market Size Growth 2020-2025 ($ millions)
Figure 27. Brazil Peptide CDMO Market Size Growth 2020-2025 ($ millions)
Figure 28. APAC Peptide CDMO Market Size Market Share by Region in 2024
Figure 29. APAC Peptide CDMO Market Size Market Share by Type (2020-2025)
Figure 30. APAC Peptide CDMO Market Size Market Share by Application (2020-2025)
Figure 31. China Peptide CDMO Market Size Growth 2020-2025 ($ millions)
Figure 32. Japan Peptide CDMO Market Size Growth 2020-2025 ($ millions)
Figure 33. South Korea Peptide CDMO Market Size Growth 2020-2025 ($ millions)
Figure 34. Southeast Asia Peptide CDMO Market Size Growth 2020-2025 ($ millions)
Figure 35. India Peptide CDMO Market Size Growth 2020-2025 ($ millions)
Figure 36. Australia Peptide CDMO Market Size Growth 2020-2025 ($ millions)
Figure 37. Europe Peptide CDMO Market Size Market Share by Country in 2024
Figure 38. Europe Peptide CDMO Market Size Market Share by Type (2020-2025)
Figure 39. Europe Peptide CDMO Market Size Market Share by Application (2020-2025)
Figure 40. Germany Peptide CDMO Market Size Growth 2020-2025 ($ millions)
Figure 41. France Peptide CDMO Market Size Growth 2020-2025 ($ millions)
Figure 42. UK Peptide CDMO Market Size Growth 2020-2025 ($ millions)
Figure 43. Italy Peptide CDMO Market Size Growth 2020-2025 ($ millions)
Figure 44. Russia Peptide CDMO Market Size Growth 2020-2025 ($ millions)
Figure 45. Middle East & Africa Peptide CDMO Market Size Market Share by Region (2020-2025)
Figure 46. Middle East & Africa Peptide CDMO Market Size Market Share by Type (2020-2025)
Figure 47. Middle East & Africa Peptide CDMO Market Size Market Share by Application (2020-2025)
Figure 48. Egypt Peptide CDMO Market Size Growth 2020-2025 ($ millions)
Figure 49. South Africa Peptide CDMO Market Size Growth 2020-2025 ($ millions)
Figure 50. Israel Peptide CDMO Market Size Growth 2020-2025 ($ millions)
Figure 51. Turkey Peptide CDMO Market Size Growth 2020-2025 ($ millions)
Figure 52. GCC Countries Peptide CDMO Market Size Growth 2020-2025 ($ millions)
Figure 53. Americas Peptide CDMO Market Size 2026-2031 ($ millions)
Figure 54. APAC Peptide CDMO Market Size 2026-2031 ($ millions)
Figure 55. Europe Peptide CDMO Market Size 2026-2031 ($ millions)
Figure 56. Middle East & Africa Peptide CDMO Market Size 2026-2031 ($ millions)
Figure 57. United States Peptide CDMO Market Size 2026-2031 ($ millions)
Figure 58. Canada Peptide CDMO Market Size 2026-2031 ($ millions)
Figure 59. Mexico Peptide CDMO Market Size 2026-2031 ($ millions)
Figure 60. Brazil Peptide CDMO Market Size 2026-2031 ($ millions)
Figure 61. China Peptide CDMO Market Size 2026-2031 ($ millions)
Figure 62. Japan Peptide CDMO Market Size 2026-2031 ($ millions)
Figure 63. Korea Peptide CDMO Market Size 2026-2031 ($ millions)
Figure 64. Southeast Asia Peptide CDMO Market Size 2026-2031 ($ millions)
Figure 65. India Peptide CDMO Market Size 2026-2031 ($ millions)
Figure 66. Australia Peptide CDMO Market Size 2026-2031 ($ millions)
Figure 67. Germany Peptide CDMO Market Size 2026-2031 ($ millions)
Figure 68. France Peptide CDMO Market Size 2026-2031 ($ millions)
Figure 69. UK Peptide CDMO Market Size 2026-2031 ($ millions)
Figure 70. Italy Peptide CDMO Market Size 2026-2031 ($ millions)
Figure 71. Russia Peptide CDMO Market Size 2026-2031 ($ millions)
Figure 72. Egypt Peptide CDMO Market Size 2026-2031 ($ millions)
Figure 73. South Africa Peptide CDMO Market Size 2026-2031 ($ millions)
Figure 74. Israel Peptide CDMO Market Size 2026-2031 ($ millions)
Figure 75. Turkey Peptide CDMO Market Size 2026-2031 ($ millions)
Figure 76. Global Peptide CDMO Market Size Market Share Forecast by Type (2026-2031)
Figure 77. Global Peptide CDMO Market Size Market Share Forecast by Application (2026-2031)
Figure 78. GCC Countries Peptide CDMO Market Size 2026-2031 ($ millions)
More Publications
Global Neuroendovascular Coil Market Growth 2025-2031
US$ 3,660.00
March 2025
85 pages
Global Homeopathy Products Market Growth (Status and Outlook) 2023-2029
US$ 3,660.00
February 2023
88 pages
Global Hospital Air Mattresses Market Growth 2024-2030
US$ 3,660.00
September 2024
118 pages
Global Scintillation Counters Market Growth 2023-2029
US$ 3,660.00
February 2023
117 pages
